Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
08/20/14 GlaxoSmithKline (GSK) Arnuity Ellipta for Asthma Subscribers Only Subscribers Only     Subscribers Only
08/20/14 GlaxoSmithKline (GSK) Amigal for Fabry's Disease Subscribers Only Subscribers Only     Subscribers Only
08/20/14 Eisai (ESALY) Fycompa for Partial Seizures (Epilepsy) Subscribers Only Subscribers Only     Subscribers Only
08/20/14 NovaBay (NBY) Aganocide for Other Ophthalmological Indications (Ophthalmology) Subscribers Only Subscribers Only     Subscribers Only
08/19/14 Emergent BioSolutions (EBS) MOR209/ES414 for Prostate Cancer Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 08/21/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/21/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/21/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/21/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 08/22/14 Subscribers Only Subscribers Only Company - Earnings Announcement